HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Electronics Business	9.00B	9.09B	9.98B	11.47B	11.05B
Electronics Business Growth	-1.01%	-8.93%	-12.99%	3.84%	-13.45%
Headquarters and Bio Business	977.23M	384.33M	200.81M	189.68M	228.18M
Headquarters and Bio Business Growth	154.27%	91.40%	5.87%	-16.87%	-66.67%
Cold Chain Business	45.93B	43.50B	14.01B	32.08B	31.80B
Cold Chain Business Growth	5.59%	210.55%	-56.33%	0.87%	-30.48%
Medical Device Business	-	-	25.48B	-	-
Inter-Segment Revenue	-977.23M	-384.33M	-1.54B	-152.71M	-146.15M
Total	54.93B	52.59B	48.13B	43.59B	42.93B
Total Growth	4.45%	9.26%	10.43%	1.53%	-27.20%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Korea	53.86B	50.98B	46.82B	41.97B	41.16B
Korea Growth	5.67%	8.86%	11.56%	1.97%	-27.08%
Japan	1.07B	1.62B	1.31B	1.58B	1.64B
Japan Growth	-33.84%	23.51%	-17.06%	-4.09%	-0.31%
United States of America	-	-	-	36.97M	109.38M
United States of America Growth	-	-	-	-66.20%	-82.24%
People's Republic of China	-	-	-	-	14.18M
People's Republic of China Growth	-	-	-	-	-94.45%
Total	54.93B	52.59B	48.13B	43.59B	42.93B
Total Growth	4.45%	9.26%	10.43%	1.53%	-27.20%

Source: S&P Global Market Intelligence.